Startups are pushing the boundaries of reproductive genetics
Advances in reproductive genetics and embryo screening are moving quickly from theory into fertility clinics, letting parents select against specific diseases and, increasingly, for traits like intelligence or appearance. Commenters weigh the promise of eliminating inherited illnesses and giving children perceived advantages against profound ethical concerns over eugenics, inequality, consent, and the risk of unintended long‑term harms to individuals and the human gene pool. Many expect regulation to lag behind practice and note that cultural values, not just technology, will determine whether these tools are used mainly for medical prevention or for broader human “enhancement.”
Pets and Non-Human Testbeds
- Several commenters suggest using pets (especially rats and dogs) as an intermediate step before human germline edits, to fix severe inbreeding and disease predispositions.
- Pet rat owners in particular describe extreme rates of tumors and respiratory illness and say they would eagerly pay for longer-lived, healthier GMO rats.
- Others joke darkly about “super rats” escaping control, hinting at ecological risks.
Billionaires, Regulation, and “Red Tape”
- One camp argues only tech billionaires are bold and rich enough to push human germline editing past regulatory obstacles and that, historically, medical tech eventually diffuses to everyone.
- Opponents question billionaire incentives and fear profit-driven abuse more than government paralysis.
- Some call for deregulated zones to allow high-risk experimentation; others insist guardrails and national bans exist for good reason.
Disease Prevention vs. Human Enhancement
- Many see editing out monogenic diseases (e.g., inherited deafness, psychosis risk, color blindness) as compassionate and ethically distinct from “designer babies.”
- Others push further: in a world mismatched to our evolved traits, they argue for editing behavioral predispositions (e.g., depression, tribalism) to better fit modern life.
- Critics respond that “improvement” is undefinable and historically weaponized (eugenics, racial projects), and that fixes for things like depression could effectively engineer a compliant underclass.
IVF, Embryo Selection, and Real-World Use
- A detailed personal account describes using whole-genome sequencing plus IVF to avoid a known hearing-loss mutation, emphasizing relief from disease rather than pursuit of perfection.
- Some biologists in the thread stress that embryo selection (not editing) is already technically feasible and ethically harder to criticize, though IVF carries real physical burdens for women.
- Others note cosmetic choices (like eye and hair color) and elective embryo selection are already happening quietly despite official bans.
Ethics, Eugenics, and Moral Status of Embryos
- Deep disagreement appears on whether embryo screening/editing is “eugenics” or simply medical repair.
- One side argues bans are cruel to people with heritable disease; the other says no one is entitled to a particular kind of child and likens large-scale embryo discard to commodifying human life.
- Long subthreads debate when human moral status begins and whether opposing gene repair is akin to opposing vaccines or surgery.
Inequality, Sports, and “Superhumans”
- Commenters worry about genetic elites in sports and society: separate leagues, exclusion of enhanced individuals, and widening genetic class divides are all imagined.
- Others counter that elite athletes are already genetic outliers and that rules will evolve pragmatically, like existing sex and weight classes.
Technical and Practical Constraints
- One contributor does back-of-the-envelope math: selecting for even five favorable gene variants via IVF would require on the order of hundreds of embryos, making broad “optimization” impractical.
- CRISPR editing in embryos is portrayed as more complex and error-prone than popular narratives suggest; off-target effects and long-term unknowns are a major concern.
Risk, Progress, and Societal Control
- A recurring theme is whether modern societies have become too risk-averse and overregulated, preventing “trajectory-changing bets” that earlier generations routinely took.
- Others reply that the stakes of germline edits—irreversible and multi-generational—justify extraordinary caution, and that suffering from earlier eras is not a good moral benchmark for today.